| (V1220) |
Long-term Safety and Efficacy of Drug Eluting and Bare Metal Stents implanted in Saphenous Vein Grafts in Sweden |
|
J. Carlsson, S. James, O. Fröbert, B. Lagerqvist, U. Stenestrand, F. Scherstén on behalf of SCAAR Studiengruppe (Kalmar, Uppsala, Örebro, Linköping, Lund, SE) |
| (V1221) |
Long term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions |
|
M. Abdel-Wahab, R. Baev, P. Dieker, G. Kassner, V. Geist, G. Richardt (Bad Segeberg) |
| (V1222) |
Two-Year Clinical and Angiographic Outcomes From a Stratified Randomized Controlled Trial of Everolimus-Eluting Xience Stents Versus Sirolimus-Eluting Cypher Stents Results of the ISAR-TEST-4 Trial |
|
S. Kufner, J. Mehilli, S. Schulz, S. Massberg, R. Byrne, A. Schömig, A. Kastrati (München) |
| (V1223) |
Randomized comparison of rapamycin/probucol with zotarolimus-eluting stent in patients with symptomatic coronary artery disease Results of the ISAR-TEST-5 Trial |
|
S. Kufner, J. Mehilli, R. Byrne, S. Schulz, S. Massberg, J. Pache, K.-L. Laugwitz, J. Hausleiter, A. Schömig, A. Kastrati (München) |
| (V1224) |
Long-Term Outcome After Sirolimus-Eluting Stents Versus Bare Metal Stents in Patients with Diabetes Mellitus: A Patient-Level Meta-Analysis of Randomized Trials |
|
A. de Waha, A. Dibra, A. Kastrati, A. Schömig (München) |
| (V1225) |
Coroflex® DEBlue vs. Cypher® Stent bei komplexen De-novo-Läsionen: IVUS-Analyse der PEPCAD-III-Studie |
|
D. Fischer, B. Scheller, A. Schaefer, G. Klein, Y. P. Clever, M. Böhm, B. Cremers (Hannover, Homburg/Saar) |